MKI67 and breast cancer: Previous studies have inferred clinicopathological features such as larger tumor size, hormone receptor status, the presence of lymph node involvement, staining extent of nuclear-associated antigen Ki- 67 (Ki-67), as adverse distinguished prognostic traits in BC.